Absence of p53-Dependent Apoptosis Combined With Nonhomologous End-Joining Deficiency Leads to a Severe Diabetic Phenotype in Mice
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Regulation of pancreatic β-cell mass is essential to preserve sufficient insulin levels for the maintenance of glucose homeostasis. Previously, we reported that DNA double-strand breaks (DSBs) resulting from nonhomologous end-joining (NHEJ) deficiency induce apoptosis and, when combined with p53 deficiency, progressed rapidly into lymphomagenesis in mice. Combination of NHEJ deficiency with a hypomorphic mutation, p53R172P, leads to the abrogation of apoptosis, upregulation of p21, and senescence in precursor lymphocytes. This was sufficient to prevent tumorigenesis. However, these mutant mice succumb to severe diabetes and die at an early age. The aim of this study was to determine the pathogenesis of diabetes in these mutant mice. RESEARCH DESIGN AND METHODS: We analyzed the morphology of the pancreatic islets and the function, proliferation rate, and senescence of β-cells. We also profiled DNA damage and p53 and p21 expression in the pancreas. RESULTS: NHEJ-p53R172P mutant mice succumb to diabetes at 3–5 months of age. These mice show a progressive decrease in pancreatic islet mass that is independent of apoptosis and innate immunity. We observed an accumulation of DNA damage, accompanied with increased levels of p53 and p21, a significant decrease in β-cell proliferation, and cellular senescence in the mutant pancreatic islets. CONCLUSIONS: Combined DSBs with an absence of p53-dependent apoptosis activate p53-dependent senescence, which leads to a diminished β-cell self-replication, massive depletion of the pancreatic islets, and severe diabetes. This is a model that connects impaired DNA repair and accumulative DNA damage, a common phenotype in aging individuals, to the onset of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mice lacking p53-dependent apoptosis, the burden of senescent cells increases rapidly and is associated with dysfunction of pancreatic β-cells, causing an overt diabetic phenotype in 3–4 months (65).”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
Dor, Y., Brown, J., Martinez, O. I., & Melton, D. A. (2004) · Nature · doi:10.1038/nature02520 · Cited by 2,219
Living on a break: cellular senescence as a DNA-damage response
d'Adda di Fagagna, F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2440 · Cited by 1,170 · cited 1×
“These properties may cause aging-related diseases (13).”
p16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · cited 2×
“Conversely, p16 (36), p18, or p27 (38) deficiency results in pancreatic islet hyperplasia.”
BackgroundRepair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining
Mahaney, B. L., Meek, K., & Lees-Miller, S. P. (2009) · Biochemical Journal · doi:10.1042/bj20080413 · Cited by 717 · cited 1×
“Classic nonhomologous end-joining (NHEJ) is one of the two major pathways for the repair of DNA double-strand breaks (DSBs) (1).”
BackgroundRane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P., & Barbacid, M. (1999) · Nature Genetics · doi:10.1038/8751 · Cited by 700 · cited 3×
“Such examples are CDK4-deficient (32,33) or Cyclin D2–deficient (18,34) mice; both models have a progressive reduction of -cell number and gross onset of diabetes with features of hyperglycemia and glucose intolerance.”
BackgroundA critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis
Gao, Y., Sun, Y., Frank, K. M., Dikkes, P., Fujiwara, Y., Seidl, K. J., Sekiguchi, J. M., Rathbun, G. A., Swat, W., Wang, J., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81714-6 · Cited by 688
Self-citationLate embryonic lethality and impaired V (D)J recombination in mice lacking DNA ligase IV
Frank, K. M., Sekiguchi, J. M., Seidl, K. J., Swat, W., Rathbun, G. A., Cheng, H.-L., Davidson, L., Kangaloo, L., & Alt, F. W. (1998) · Nature · doi:10.1038/24172 · Cited by 594
Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development
Gao, Y., Ferguson, D. O., Xie, W., Manis, J. P., Sekiguchi, J., Frank, K. M., Chaudhuri, J., Horner, J., DePinho, R. A., & Alt, F. W. (2000) · Nature · doi:10.1038/35009138 · Cited by 580 · cited 1×
“The embryonic lethality is rescued by p53 deficiency (6,9).”
BackgroundGrowth and Regeneration of Adult β Cells Does Not Involve Specialized Progenitors
Teta, M., Rankin, M. M., Long, S. Y., Stein, G. M., & Kushner, J. A. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.011 · Cited by 551
Cited by
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
Palmer, A. K., Tchkonia, T., LeBrasseur, N. K., Chini, E. N., Xu, M., & Kirkland, J. L. (2015) · Diabetes · doi:10.2337/db14-1820 · Cited by 423
“In mice lacking p53-dependent apoptosis, the burden of senescent cells increases rapidly and is associated with dysfunction of pancreatic b-cells, causing an overt diabetic phenotype in 3–4 months (65).”
BackgroundControl of metabolism by p53 – Cancer and beyond
Labuschagne, C. F., Zani, F., & Vousden, K. H. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.001 · Cited by 219
“While several studies suggest that the pathologies associated with p53 activation reflects enhanced activation of cell death, mice carrying a mutant p53 that has no apoptotic activity but retains cell cycle arrest function were also found to have a greater susceptibility to diabetes [135], suggesting a role for p53-in…”
BackgroundThe role of the p53 tumor suppressor in metabolism and diabetes
Kung, C.-P., & Murphy, M. E. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0324 · Cited by 178
NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?
Sahoo, S., Meijles, D. N., & Pagano, P. J. (2016) · Clinical Science · doi:10.1042/cs20150087 · Cited by 146
“Finally, redox activation of p53/p21cip signalling leading to senescence is evident in murine models of hypertension [151,152], diabetes [153,154], atherosclerosis [155,156] and pulmonary hypertension [121,157].”
BackgroundGenetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes
Dooley, J., Tian, L., Schonefeldt, S., Delghingaro-Augusto, V., Garcia-Perez, J. E., Pasciuto, E., Di Marino, D., Carr, E. J., Oskolkov, N., Lyssenko, V., et al. (2016) · Nature Genetics · doi:10.1038/ng.3531 · Cited by 145
Emerging Roles of p53 Family Members in Glucose Metabolism
Itahana, Y., & Itahana, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030776 · Cited by 126
“Mice with an NHEJ (non-homologous end joining) deficiency undergo rapid lymphomagenesis, and a hypomorphic p53 mutant p53R172P that lacks apoptotic function but retains the ability to induce senescence can rescue lymphomagenesis, but also induces severe diabetes accompanied with the senescence of pancreatic β cells [1…”
BackgroundThe P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction
Kung, C.-P., Leu, J. I.-J., Basu, S., Khaku, S., Anokye-Danso, F., Liu, Q., George, D. L., Ahima, R. S., & Murphy, M. E. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.037 · Cited by 106
“Cell disease, obesity, and type 2 diabetes (Minamino et al., 2009; Ortega et al., 2014; Sano et al., 2007; Tavana et al., 2010).”
Tse, K., & Herrup, K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14079 · Cited by 105
“DSBs increase in the ageing pancreas (Wiktor-Brown et al. 2006), and in mice deficient for ligase IV (a major NHEJ mediator), the b-cells suffer from increased DSBs, arrested cell cycle and pancreatic islet degeneration – a phenotype typical of diabetes (Tavana et al. 2010).”
BackgroundInterventions for age-related diseases: Shifting the paradigm
Figueira, I., Fernandes, A., Mladenovic Djordjevic, A., Lopez-Contreras, A., Henriques, C. M., Selman, C., Ferreiro, E., Gonos, E. S., Trejo, J. L., Misra, J., et al. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.009 · Cited by 87
Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoform
Slatter, T. L., Hung, N. A., Campbell, H. G., Rubio, C., Mehta, R., Renshaw, P., Williams, G., Wilson, M., Engelmann, A., Jeffs, A. R., et al. (2011) · Blood · doi:10.1182/blood-2010-11-321851 · Cited by 90
de Bruin, C., Verónica Mericq, G., Andrew, S. F., van Duyvenvoorde, H. A., Verkaik, N. S., Losekoot, M., Porollo, A., García, H., Kuang, Y., Hanson, D., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1098 · Cited by 75
Tavana, O., Benjamin, C. L., Puebla-Osorio, N., Sang, M., Ullrich, S. E., Ananthaswamy, H., & Zhu, C. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12688 · Cited by 63
Self-citationβ-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes
Horwitz, E., Krogvold, L., Zhitomirsky, S., Swisa, A., Fischman, M., Lax, T., Dahan, T., Hurvitz, N., Weinberg-Corem, N., Klochendler, A., et al. (2018) · Diabetes · doi:10.2337/db17-1006 · Cited by 64
“For example, mutation in DNA ligase IV leads to spontaneous b-cell apoptosis and insulin-dependent hyperglycemia (6).”
BackgroundType 2 Diabetes in the Elderly: Challenges in a Unique Patient Population
Bradley, D. P., & Hsueh, W. A. (2016) · Journal of Geriatric Medicine and Gerontology · doi:10.23937/2469-5858/1510014 · Cited by 67
Δ40 Isoform of p53 Controls β-Cell Proliferation and Glucose Homeostasis in Mice
Hinault, C., Kawamori, D., Liew, C. W., Maier, B., Hu, J., Keller, S. R., Mirmira, R. G., Scrable, H. J., & Kulkarni, R. (2011) · Diabetes · doi:10.2337/db09-1379 · Cited by 58
“(44) describe the phenotypes of 1-month-old mice doubly mutant for p53 and nonhomologous end-joining deficiency that exhibit an ;50% decrease in b-cell mass and yet manifest blood glucose levels that are not significantly different from controls.”
BackgroundPancreatic β-cell senescence in diabetes: mechanisms, markers and therapies
Cha, J., Aguayo‐Mazzucato, C., & Thompson, P. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1212716 · Cited by 54
“X, Early Loss of beta cell mass, insulin deficiency, diabetes Yes No effect on alpha cells (100)”
BackgroundRieck, S., Zhang, J., Li, Z., Liu, C., Naji, A., Takane, K. K., Fiaschi‐Taesch, N., Stewart, A. F., Kushner, J. A., & Kaestner, K. H. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1019 · Cited by 55
“In these mice, -cell mass is progressively depleted due to double stranded DNA damage-induced senescence (19).”
BackgroundMethodIs p53 Involved in Tissue‐Specific Insulin Resistance Formation?
Strycharz, J., Drzewoski, J., Szemraj, J., & Śliwińska, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9270549 · Cited by 50
The role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
Dual Role of Nitric Oxide in Regulating the Response of β Cells to DNA Damage
Oleson, B. J., & Corbett, J. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7351 · Cited by 49
Brawerman, G. M., Pipella, J., & Thompson, P. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101524 · Cited by 38
Li, X., Wang, T., Tao, Y., Wang, X., Li, L., & Liu, J. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022003 · Cited by 31
“Moreover, p53-mediated senescence would diminish self-replication of pancreatic beta cell and severe diabetes [29].”
BackgroundSenescence and Type 2 Diabetic Cardiomyopathy: How Young Can You Die of Old Age?
Henson, S. M., & Aksentijević, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716517 · Cited by 25
“In transgenic mice lacking p53-dependent apoptosis, the number of senescent cells rapidly increases and is associated with dysfunction of pancreatic β cells, causing an overt diabetic phenotype (Tavana et al., 2010).”
BackgroundGuevara, A., McGowan, S. J., Kazantzis, M., Stallons, T. A. R., Sano, T., Mulder, N. L., Jurdzinski, A., van Dijk, T. H., Eggen, B. J. L., Jonker, J. W., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154711 · Cited by 22
“This phenotype is associated with decreased beta-cell proliferation, and occurs even when these mice have normal insulin sensitivity [11].”
BackgroundTCF19 Impacts a Network of Inflammatory and DNA Damage Response Genes in the Pancreatic β-Cell
Yang, G. H. Y., Fontaine, D. A., Lodh, S., Blumer, J. T., Roopra, A., & Davis, D. B. (2021) · Metabolites · doi:10.3390/metabo11080513 · Cited by 20
“Sustained DNA damage can eventually result in cellular apoptosis [54].”
BackgroundHuang, Y., Wang, D., Zhang, W., Xue, Y., Li, K., Zhang, Y., & Zeng, M. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18043 · Cited by 22
“43 Additionally, p21, as a downstream target of P53 and a regulator of the cell cycle, has been reported to play a role in the regulation of the regeneration capacity of pancreatic beta cells.”
BackgroundA novel Ku70 function in colorectal homeostasis separate from nonhomologous end joining
Puebla‐Osorio, N., Kim, J. J., Ojeda, S. S., Zhang, H., Tavana, O., Li, S., Wang, Y., Ma, Q., Schluns, K. S., & Zhu, C. (2013) · Oncogene · doi:10.1038/onc.2013.234 · Cited by 18
Self-citationRanta, F., Leveringhaus, J., Theilig, D. C., Schulz‐Raffelt, G., Hennige, A. M., Hildebrand, D. G., Handrick, R., Jendrossek, V., Bosch, F., Schulze‐Osthoff, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028828 · Cited by 16
“In the second study using a mouse model with deficient DNA repair reduced b-cell proliferation and the onset of diabetes was accompanied by increased expression of p21 [43].”
BackgroundDong, Y., Qian, C., Wan, G., Yan, P., Liang, S., & Wang, J. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.10.026 · Cited by 20
RetractedGiovos, G., Yavropoulou, M. P., & Yovos, J. G. (2019) · HORMONES · doi:10.1007/s42000-019-00132-6 · Cited by 17
“In another mouse model of impaired homologous endjoining (NHEJ) DNA repair mechanisms, which leads to embryonic lethality, deletion of p53 rescues from lethality but causes rapid pancreatic β-cell dysfunction and results in an overt diabetic phenotype in 3–4 months due to senescence in pancreatic β cells [60].”
BackgroundTargeting p53-p21 signaling to enhance mesenchymal stem cell regenerative potential
Goyal, A., Afzal, M., Khan, N. H., Goyal, K., Srinivasamurthy, S. K., Gupta, G., Kumar, K., Ali, H., Rana, M., Wong, L. S., et al. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.03.007 · Cited by 12
Ahn, C. H., Choi, E. H., Oh, T. J., & Cho, Y. M. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04406-6 · Cited by 11
“Senescent β cells lose regenerative potential, eventually leading to decreased β cell mass [14].”
BackgroundKu70 Functions in Addition to Nonhomologous End Joining in Pancreatic β-Cells
Tavana, O., Puebla‐Osorio, N., Kim, J., Sang, M., Jang, S., & Zhu, C. (2013) · Diabetes · doi:10.2337/db12-1218 · Cited by 12
Self-citationFailure to Repair Endogenous DNA Damage in β-Cells Causes Adult-Onset Diabetes in Mice
Yousefzadeh, M. J., O'Kelly, R. D., Wade, E. A., Gonzalez-Espada, L. V., Henessy-Wack, D., Howard, S., Rozgaja, T. A., Trussoni, C. E., LaRusso, N. F., Eggen, B. J. L., et al. (2023) · doi:10.59368/agingbio.20230015 · Cited by 11
“Furthermore, mice with de fi cient double-strand break repair and impaired p53 signaling develop severe diabetes 43 .”
BackgroundHu, S., Ouyang, J., Zheng, G., Lu, Y., Zhu, Q., Wang, B., Ye, L., & Zhu, C. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.05.046 · Cited by 10
Self-citationEstablishing evidence for immune surveillance of β-cell senescence
Morelli, N. R., Pipella, J., & Thompson, P. J. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.01.003 · Cited by 9
Stempkowska, A., Walicka, M., Franek, E., Naruszewicz, M., Pańczyk, M., Sanchak, Y., & Filipek, A. (2020) · Genes · doi:10.3390/genes11111253 · Cited by 8
“Studies in an animal model (Lig4−/−; p53−/− mice) have confirmed that p53-mediated aging of adipocytes and p53-mediated pancreatic β cells induces the development of insulin resistance and diabetes [34].”
BackgroundExocrine pancreatic inflammation in canine diabetes mellitus – An active offender?
Johnson‐Pitt, A., Catchpole, B., & Davison, L. J. (2024) · The Veterinary Journal · doi:10.1016/j.tvjl.2024.106241 · Cited by 8
Analyzing Amylin Aggregation Inhibition Through Quantum Dot Fluorescence Imaging
Yin, X., Liu, Z., Huanood, G., Sawatari, H., Shimamori, K., Kuragano, M., & Tokuraku, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011132 · Cited by 4
“The massive apoptosis of β cells diminishes insulin secretion, leading to prediabetes or diabetes [15].”
Background[The effect of deep branches of cervical nerve on motorial function of trapezius muscle].
Wang, F., Wen, Y., & Li, L. (2003) · 华西口腔医学杂志 · Cited by 4
Pancreatic β-Cell Senescence: Mechanisms and Association with Diabetes
Ahmed, S. M., Elshenawy, S. E., Sedky, S., Elmehrath, A. O., & El‐Badri, N. (2021) · European Medical Journal · doi:10.33590/emj/20-00128 · Cited by 5
Insulin production is sustained during DNA damage-mediated senescence in adult human beta cells
Préfontaine, C., Pipella, J., Morelli, N. R., Chen, Y., Verchere, C. B., & Thompson, P. J. (2025) · Diabetologia · doi:10.1007/s00125-025-06603-3 · Cited by 3
“NHEJ is a major pathway for DNA double-strand break repair in non-dividing cells [32] and disruption or polymorphisms in components of NHEJ repair leads to beta cell apoptosis or senescence in mouse models [33, 34].”
Aging and Cardiovascular Diseases: The Role of Cellular Senescence
Bozaykut, P. (2019) · Springer eBooks · doi:10.1007/978-981-13-8273-4_10 · Cited by 3
Varghese, S. S., Peña, A. G. H.-D. L., & Dhawan, S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231519 · Cited by 3
Altınkaya, S. Ö., Avcıoğlu, S. N., Sezer, S. D., & Ceylaner, S. (2019) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14071 · Cited by 2
GDM links to increased neonatal myocardial hypertrophy via ANGPTL7: prospective cohort study
Jian, W., Shi, S., Yang, X., Huang, Y., Du, C., He, M., Li, X., Huang, M., Yuan, R., Lin, W., et al. (2025) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2025.2531366 · Cited by 1
“…angiogenesis (sun et al. 2022), our findings suggest its involvement in insulin signalling pathways. the observed irs1/sOcs3 interaction mechanism (tavana et al. 2010) provides plausible explanation for GDM-associated cardiac remodelling: Hyperinsulinemia-induced ANGPtL7 overexpression may…”
Wei, Z., Xu, T., Gu, X., He, Q., Feng, Q., & Li, M. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07981-x · Cited by 1
“CDKN1C, a cyclin-dependent kinase inhibitor, regulates cell cycle progression and plays a crucial role in maintaining the identity of terminally differentiated cells [58].”
Lai, S., Higuchi, T., Tsuda, M., Sugiyama, Y., Morisawa, K., Taniguchi, T., & Sakamoto, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-12600-y · Cited by 1
Pancreatic β-Cell Senescence: A Contributor to Type 2 Diabetes
Urmi, R., Singh, R., Singh, M., & Sinha, B. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-1041-9_8 · Cited by 1
DOUBLE-STRAND BREAK REPAIR PATHWAYS IN DNA STRUCTURE-INDUCED GENETIC INSTABILITY
Kha, D. T. (2010) · Digital Commons-TMC (Texas Medical Center)
Zheng, G., Zhu, Q., Dong, J., Lin, X., & Zhu, C. (2019) · BMC Biotechnology · doi:10.1186/s12896-019-0573-z
Self-citationInteractions between DNA damage and metabolism
Guevara, A. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.123699652
Senotherapeutics: Experimental therapy of cellular senescence
Justice, J. N., Niedernhofer, L. J., & Orr, M. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00012-3
Current literature in diabetes
(2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1023
Pereira, P., Syed, J. M., Chalasani, S. H., Tejeswini, C. J., Avarebeel, S., & Ramesh, K. (2024) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2024.100207
Dipu, M., Richi, S. N., Saha, S., Islam, M. M., Chakma, P., Ibnat, N., & Rahman, M. A. (2026) · Food and Humanity · doi:10.1016/j.foohum.2026.101490
Genetics of type 2 diabetes: Beyond single nucleotide variant studies
Moya-Valera, C., Gallardo-Espinoza, M. D. J., Arita, A. F., Lara-Hernández, F., Quiroz-Rodríguez, M. E., Abellán, R., Garcia-Garcia, A.-B., & Chaves, F. J. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102449
Metadata
- Authors
- Tavana, O., Puebla-Osorio, N., Sang, M., & Zhu, C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Department of Immunology, University of Texas, M.D. Anderson Cancer Center, Houston, Texas;
- Corresponding author
- Zhu, Chengming
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-10-15
- Volume
- 59
- Issue
- 1
- Pages
- 135-142
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2797914
- OpenAlex
- W2139190473
- Cited by
- 58
- References
- 43
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 3 · 2019: 5 · 2018: 3 · 2017: 4 · 2016: 6 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (CA-116933, R01CA116933)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p53, DNA double-strand breaks, beta-cell mass, cellular senescence, p21, DNA damage, pancreatic islets, beta-cell proliferation, DNA repair, aging, lymphomagenesis
- MeSH terms
- DNA Ligase ATP, Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Experimental, DNA Damage, DNA-Binding Proteins, Immunity, Innate, Immunohistochemistry, Insulin, Islets of Langerhans, Mice, Inbred C57BL, Mice, Inbred Strains, Pancreas, Phenotype, DNA Ligases, Tumor Suppressor Protein p53, Cellular Senescence, Glucose Intolerance, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.